关键数据
164.570今开
168.360最高
1.31M成交量
38.36市盈率 TTM
20.27市盈率动
--股息TTM
1.90%换手率
165.680昨收
162.425最低
156.84M成交额
27.38市盈率静
8.79市净率
0.00%股息率 TTM
9.31%ROA
354.88052周最高
1.11量比
418.30M净利润
69.26M总股本
4.3105每股收益TTM
1.14Beta
23.00%ROE
140.63052周最低
3.58%振幅
69.45%毛利率
11.45B总市值
0.34回报/风险
2.14%风险率
操作建议
Insulet Corp当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名14/199位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价243.88。中期看,股价处于平稳状态。近一个月,市场表现一般,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
压力支撑

由于公司未披露,未能获取相关数据
Insulet Corp新闻
即将为您带来更多新闻,敬请期待。。。
收益预测
Zimmer Biomet Holdings Inc
ZBH
31
技术指标
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
Insulet Corp简介
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.
公司代码PODD
公司Insulet Corp
CEOMcevoy (Ashley)
网址https://www.omnipod.com
公司股东
常见问题
Insulet Corp(PODD)的当前股价是多少?
Insulet Corp(PODD)的当前股价是 165.35。
Insulet Corp股票的52周最高点是多少?
Insulet Corp股票的52周最高点是354.88。
Insulet Corp股票的52周最低点是多少?
Insulet Corp股票的52周最低点是140.63。
现在Insulet Corp(PODD)的股票是买入、持有还是卖出?
根据分析师评级,Insulet Corp(PODD)的总体评级为买入,目标价格为243.88。
Insulet Corp(PODD)股票的每股收益(EPS TTM)是多少
Insulet Corp(PODD)股票的每股收益(EPS TTM)是3.51。